Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,297-1,308 of 4,306
Behavioral study icon
Not recruitingISRCTN20328848

Primary prevention of psychosis through interventions in the prodromal phase

This study is looking at whether cognitive behavioural therapy can help people with First episode psychosis, schizophrenia/prodromal, ultra-high risk state/primary prevention or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In Norway
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
Norway
Sponsor
Stavanger University Hospital (Norway)
Condition
Schizophrenia
Other study type icon
Not recruitingISRCTN21353122

The prevention of psychosis in at risk mental state

This study is looking at whether In both arms treatment as usual will be provided for the complaints that made the person seek help can help people with Psychosis, Mental and Behavioural Disorders, or Mental disorder. Participants take part in In both arms treatment as usual will be provided for the complaints that made the person seek help and complete follow-up assessments.

In Netherlands
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
Netherlands
Sponsor
The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)
Condition
Schizophrenia
Behavioral study icon
Not recruitingISRCTN04199273

WELLFOCUS study: to investigate an intervention to improve well-being in people with psychosis

This study is looking at a support or therapy approach for people with Psychosis, Mental and Behavioural Disorders, or Unspecified organic or symptomatic mental disorder. Participants take part in the program or support approach and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
United Kingdom
Sponsor
King’s College London (UK)
Condition
Schizophrenia
Drug study icon
CompletedNCT06068465

Safety study of safety and Efficacy of Pimavanserin in Schizophrenia

This study is completed in China. It is testing safety and Efficacy of Pimavanserin for Schizophrenia.

Multiple locations, including Hefei
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.Over 40 Years
Countries
China
Sponsor
Tasly Pharmaceutical Group Co., Ltd
Condition
Schizophrenia
Drug study icon
WithdrawnNCT05344365

Iloperidone for Schizophrenia

This study was withdrawn in the United States. It is testing iloperidone for Schizophrenia.

In St. Petersburg
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 65 Years
Countries
United States
Sponsor
Vanda Pharmaceuticals
Condition
Schizophrenia
Drug study icon
CompletedNCT02969369

Safety study of SEP-363856 in Schizophrenia

This study is completed in the United States. It is testing SEP-363856 for Schizophrenia.

Multiple locations, including Fresno
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 55 Years to 105 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Other study type icon
Active Not RecruitingNCT05905003

AMP SCZ® Observational Study: PREDICT-DPACC

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Irvine
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 12 Years to 30 Years
Countries
United States, Australia, Canada, ...
Sponsor
Brigham and Women's Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT00526877

Long-acting Risperidone for schizophrenia

This study is completed in Taiwan. It is testing Long-acting Risperidone for schizophrenia.

In Taipei
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
Taiwan
Sponsor
Johnson & Johnson Taiwan Ltd
Condition
Schizophrenia
Drug study icon
CompletedNCT02983188

Berberine as Adjuvant Treatment for Schizophrenia Patients

This summary needs review. Please check the official study record and contact the research team for details.

In Tuenmen
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
China
Sponsor
The University of Hong Kong
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.